Avadel Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $68,129 | $52,511 | $50,410 | $50,025 |
Gross Profit | 61,763 | 46,934 | 45,598 | 43,870 |
EBITDA | -3,001 | -1,593 | 1,318 | |
EBIT | -2,261 | 283 | ||
Net Income | 9,665 | -4,920 | -5,043 | -2,625 |
Net Change In Cash | 68,129 | 52,511 | 50,410 | 50,025 |
Free Cash Flow | 12,516 | -8,232 | 7,873 | -6,890 |
Cash | 63,402 | 56,370 | 51,371 | 28,582 |
Basic Shares | 96,777 | 96,601 | 96,395 | 96,300 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $169,117 | $27,963 | $1,496 | $0 |
Gross Profit | 153,840 | 27,117 | -1,493 | -815 |
EBITDA | -35,568 | -149,125 | -97,604 | -84,784 |
EBIT | -38,249 | -150,891 | -99,097 | -85,599 |
Net Income | -48,832 | -160,276 | -137,464 | -77,329 |
Net Change In Cash | 169,117 | 27,963 | 1,496 | 0 |
Cost of Revenue | -20,118 | |||
Free Cash Flow | -46,907 | -128,511 | -71,020 | -77,336 |
Cash | 51,371 | 31,167 | 73,981 | 50,708 |
Basic Shares | 95,141 | 80,174 | 60,094 | 58,535 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.10 |
2025-03-31 | -$0.05 |
2024-12-31 | -$0.05 |
